List of VIRxSYS patents | 7 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8053232 Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing	Patent 8053232 was granted and assigned to VIRxSYS on November, 2011 by the United States Patent and Trademark Office.	VIRxSYS	United States Patent and Trademark Office	8053232	November 8, 2011
‌ US Patent 7399753 Trans-splicing mediated photodynamic therapy	Patent 7399753 was granted and assigned to VIRxSYS on July, 2008 by the United States Patent and Trademark Office.	VIRxSYS	United States Patent and Trademark Office	7399753	July 15, 2008
‌ US Patent 7427474 High-throughput methods for identifying gene function using lentiviral vectors	Patent 7427474 was granted and assigned to VIRxSYS on September, 2008 by the United States Patent and Trademark Office.	VIRxSYS	United States Patent and Trademark Office	7427474	September 23, 2008
‌ US Patent 7879321 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production	Patent 7879321 was granted and assigned to VIRxSYS on February, 2011 by the United States Patent and Trademark Office.	VIRxSYS	United States Patent and Trademark Office	7879321	February 1, 2011
‌ US Patent 8043611 Regulated nucleic acid expression system	Patent 8043611 was granted and assigned to VIRxSYS on October, 2011 by the United States Patent and Trademark Office.	VIRxSYS	United States Patent and Trademark Office	8043611	October 25, 2011
‌ US Patent 7871795 Targeted	Patent 7871795 was granted and assigned to VIRxSYS on January, 2011 by the United States Patent and Trademark Office.	VIRxSYS	United States Patent and Trademark Office	7871795	January 18, 2011
‌ US Patent 8883753 Expression of apoAI and variants thereof using spliceosome mediated RNA	Patent 8883753 was granted and assigned to VIRxSYS on November, 2014 by the United States Patent and Trademark Office.	VIRxSYS	United States Patent and Trademark Office	8883753	November 11, 2014